News & Events

  • Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer’s disease

    B-SMART partner VIB announces the publication of a new paper in the journal EMBO Molecular Medicine. In it,  Prof. Roosmarijn Vandenbroucke and her research team report that tumor necrosis factor (TNF), via activation of its receptor TNFR1, is the main inflammatory upstream mediator of the with Alzheimer’s disease (AD) associated changes at...
    Read more
  • New blood test to detect early signs of Alzheimer's

    A team of Australian and Japanese scientists has developed a blood test to detect a toxic protein, amyloid beta, which is connected to Alzheimer’s disease. First tests were able to identify the protein with 90% accuracy. Amyloid beta builds up in the brain during the disease; by measuring the proportions of amyloid fragment in the blood, the...
    Read more
  • Refining B-SMART research and cooperation

    From 01 to 02 February 2018, the B-SMART consortium came together for its 2nd Progress Meeting in Malvern, UK to discuss and align the project’s scientific work and further collaboration. The meeting was hosted by B-SMART partner Malvern Instruments Ltd (Malvern) on their premises. The two meeting days were preceded by a workshop on Dynamic...
    Read more
  • USC video about their work in B-SMART

    The Alonso’s Lab has organized its annual mini-congress at the end of last year. This event is aimed to motivate and encourage PhD students and Post-Doctoral fellows to present their work in an attractive way, yet not losing the essence of the work. The video format was the preferred choice in most presentations. The scientific sessions were about...
    Read more
  • First RNA interference drug on the steps of FDA approval

    Positive results in a clinical trial using patisiran, a RNA interference (RNAi) drug, illustrates that the B-SMART consortium is on the right track: Similar to the therapeutics addressed in B-SMART, patisiran is a therapeutic that silences a disease-causing protein  in patients with hereditary amyloidosis (hATTR), and showed excellent result...
    Read more
  • US National Academy of Medicine honours B-SMART partner María José Alonso

    María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the Universidade de Santiago de Compostela (USC) has joined the US National Academy of Medicine as International Member. After being elected one year ago, the official welcome ceremony for the Class of 2016 took place on October 14, 2017 during the 47th Annual...
    Read more
  • Meet the European Nanomedicine community at the ETPN2017

    The 12th annual meeting of the European Technology Platform on Nanomedicine (ETPN) will take place from October 17-19, 2017 in Malaga/ Spain. The event is co-organized by ETPN, BIONAND, CIBER BBN, IMDEA Nanociencia, and Nanomed Spain. The ETPN2017 is announced as “unique place to discover, to meet, to network, to prepare new projects, to...
    Read more
  • Annual Meeting & Exposition of the Controlled Release Society

    Collaborate, Connect, Innovate – The dynamic motto of the Controlled Release Society (CRS) characterised this year’s Annual Meeting & Exposition. The event took place in Boston, USA from July 16-19, 2017 and is a highlight in the conference calendar for delivery scientists as it covers new technologies and inspiring research in the rapidly...
    Read more